Affiliation:
1. Ziskind Laboratories (Hematology Section) of the Joseph H. Pratt and New England Center Hospitals, and the Department of Medicine, Tufts College Medical School, Boston, Mass. This work was completed under contract AT(30-1) 1276 between the Atomic Energy Commission and the New England Center Hospital.
Abstract
Abstract
1. The serum of a patient with thrombotic thrombocytopenic purpura was found to contain an agglutinin active against sheep red cells and heterologous platelets (dog, rabbit and rat), but not against human platelets. The activity of the agglutinin was not affected by absorption with gels, treatment with ion-exchange resins, filtration through Seitz filters or heating of the serum at 56 C. The antibody was found to be present in the salt soluble fraction of the serum proteins. The agglutinin could not be eluted from the agglutinated platelets, was absorbed completely by guinea pig kidney and incompletely by beef erythrocyte antigen (Forssman’s variety).
2. Ability to agglutinate heterologous platelets was found to be a property of sera exhibiting a high titer of heterophil antibodies of the Forssman or non-Forssman variety.
3. It is not likely that the presence of such heterophil agglutinin was of importance in the pathogenesis of the hemolytic anemia and thrombocytopenia of the patient; rather, it could be an effect of the active lytic process of red cells and platelets. Whether the finding had diagnostic significance in the ill-defined syndrome of thrombotic thrombocytopenic purpura remains to be established with the observation of further cases.
Publisher
American Society of Hematology
Subject
Cell Biology,Hematology,Immunology,Biochemistry
Cited by
35 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献